Robshaw & Julian Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$6.21M Buy
46,935
+200
+0.4% +$25.5K 4.45% 5
2017
Q1
$5.82M Buy
46,735
+910
+2% +$109K 4.2% 6
2016
Q4
$5.28M Sell
45,825
-150
-0.3% -$17.3K 3.9% 6
2016
Q3
$5.43M Sell
45,975
-100
-0.2% -$12.1K 4.03% 4
2016
Q2
$5.59M Sell
46,075
-7,765
-14% -$882K 4.26% 2
2016
Q1
$5.83M Sell
53,840
-1,110
-2% -$115K 4.39% 3
2015
Q4
$5.64M Sell
54,950
-700
-1% -$70.4K 4.37% 3
2015
Q3
$5.2M Buy
55,650
+1,400
+3% +$135K 4.39% 4
2015
Q2
$5.29M Sell
54,250
-300
-0.5% -$30K 4.06% 6
2015
Q1
$5.37M Buy
54,550
+1,350
+3% +$137K 4.04% 5
2014
Q4
$5.56M Buy
53,200
+500
+0.9% +$52.7K 4.37% 7
2014
Q3
$5.62M Buy
52,700
+950
+2% +$98.5K 4.43% 4
2014
Q2
$5.41M Sell
51,750
-2,425
-4% -$245K 4.15% 4
2014
Q1
$5.32M Buy
54,175
+3,325
+7% +$308K 4.1% 4
2013
Q4
$4.66M Buy
50,850
+61
+0.1% +$5.62K 3.85% 7
2013
Q3
$4.4M Buy
50,789
+2,211
+5% +$198K 3.74% 6
2013
Q2
$4.17M Buy
+48,578
New +$4.12M 3.92% 7

Other funds holding JNJ

Robshaw & Julian Associates's JNJ Position: Q2 2017 in Review

Robshaw & Julian Associates increased its Johnson & Johnson (JNJ) stake by 0.43% in Q2 2017, buying an estimated $25.5K and bringing the position to 46,935 shares worth $6.21M. The position accounts for 4.45% of the portfolio, ranked #5.

Robshaw & Julian Associates first reported a position in JNJ in Q2 2013 and has held it in 17 quarters since. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Robshaw & Julian Associates held 46,935 shares of Johnson & Johnson worth $6.21M as of Q2 2017.
  • Robshaw & Julian Associates bought 200 Johnson & Johnson shares in Q2 2017, an estimated $25.5K.
  • Johnson & Johnson made up 4.45% of Robshaw & Julian Associates's portfolio in Q2 2017, its #5 holding.
  • Robshaw & Julian Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 17 quarters since.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Robshaw & Julian Associates's 13F filing for Q2 2017, filed 3 Aug 2017.